verapamil has been researched along with protoporphyrin ix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farshi, SS; Hasan, T; Iinuma, S; Ortel, B | 1 |
| Harada, H; Hiyoshi, M; Okada, S; Suzu, S; Yamamoto, K; Yoshidomi, Y | 1 |
2 other study(ies) available for verapamil and protoporphyrin ix
| Article | Year |
|---|---|
A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin.
Topics: Aminolevulinic Acid; Animals; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Cell Division; Cells, Cultured; Deferoxamine; Ferrochelatase; Fibroblasts; Humans; Melanoma; Mice; Microscopy, Fluorescence; Mitochondria; Photochemotherapy; Protoporphyrins; Rats; Skin Neoplasms; Spectrometry, Fluorescence; Tumor Cells, Cultured; Up-Regulation; Urinary Bladder Neoplasms; Verapamil | 1994 |
Erythroblasts highly express the ABC transporter Bcrp1/ABCG2 but do not show the side population (SP) phenotype.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Erythroblasts; Flow Cytometry; Gene Expression Regulation; Hematopoietic Stem Cells; Mice; Mice, Inbred C57BL; Phenotype; Protoporphyrins; Staining and Labeling; Verapamil | 2007 |